SynthesisAfrican health sciences2023

Therapeutic outcome of dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.

Changlun Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.